- Home
- TECH vs SRAD Comparison
TECH vs SRAD Comparison
Compare TECH & SRAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- SRAD
- Stock Information
- Founded
- TECH 1976
- SRAD 2001
- Country
- TECH United States
- SRAD Switzerland
- Employees
- TECH N/A
- SRAD N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- SRAD Computer Software: Programming Data Processing
- Sector
- TECH Health Care
- SRAD Technology
- Exchange
- TECH Nasdaq
- SRAD Nasdaq
- Market Cap
- TECH 7.8B
- SRAD 6.8B
- IPO Year
- TECH 1989
- SRAD 2021
- Fundamental
- Price
- TECH $49.89
- SRAD $25.40
- Analyst Decision
- TECH Buy
- SRAD Strong Buy
- Analyst Count
- TECH 11
- SRAD 14
- Target Price
- TECH $72.00
- SRAD $26.64
- AVG Volume (30 Days)
- TECH 2.5M
- SRAD 1.5M
- Earning Date
- TECH 08-06-2025
- SRAD 08-12-2025
- Dividend Yield
- TECH 0.64%
- SRAD N/A
- EPS Growth
- TECH N/A
- SRAD 114.88
- EPS
- TECH 0.83
- SRAD 0.20
- Revenue
- TECH $1,208,770,000.00
- SRAD $1,245,020,536.00
- Revenue This Year
- TECH $7.07
- SRAD $17.66
- Revenue Next Year
- TECH $5.88
- SRAD $15.21
- P/E Ratio
- TECH $60.23
- SRAD $127.78
- Revenue Growth
- TECH 4.72
- SRAD 23.07
- 52 Week Low
- TECH $46.01
- SRAD $10.06
- 52 Week High
- TECH $83.62
- SRAD $26.19
- Technical
- Relative Strength Index (RSI)
- TECH 49.63
- SRAD 64.37
- Support Level
- TECH $49.05
- SRAD $24.06
- Resistance Level
- TECH $51.66
- SRAD $25.44
- Average True Range (ATR)
- TECH 1.59
- SRAD 0.77
- MACD
- TECH 0.17
- SRAD 0.08
- Stochastic Oscillator
- TECH 47.40
- SRAD 72.04
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About SRAD Sportradar Group AG
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.